Skandinaviska Enskilda Banken (SEB)’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02M | Hold |
114,063
| – | – | ﹤0.01% | 646 |
|
|
2025
Q1 | $855K | Hold |
114,063
| – | – | ﹤0.01% | 655 |
|
|
2024
Q4 | $859K | Hold |
114,063
| – | – | ﹤0.01% | 670 |
|
|
2024
Q3 | $867K | Hold |
114,063
| – | – | ﹤0.01% | 683 |
|
|
2024
Q2 | $705K | Hold |
114,063
| – | – | ﹤0.01% | 663 |
|
|
2024
Q1 | $579K | Sell |
114,063
-76,478
| -40% | -$389K | ﹤0.01% | 699 |
|
|
2023
Q4 | $1.14M | Hold |
190,541
| – | – | 0.01% | 680 |
|
|
2023
Q3 | $1.35M | Hold |
190,541
| – | – | 0.01% | 630 |
|
|
2023
Q2 | $1.34M | Buy |
190,541
+96,101
| +102% | +$676K | 0.01% | 647 |
|
|
2023
Q1 | $788K | Sell |
94,440
-4,646
| -5% | -$38.8K | 0.01% | 724 |
|
|
2022
Q4 | $1.14M | Sell |
99,086
-5,743
| -5% | -$66K | 0.01% | 655 |
|
|
2022
Q3 | $1.32M | Hold |
104,829
| – | – | 0.01% | 619 |
|
|
2022
Q2 | $1.11M | Hold |
104,829
| – | – | 0.01% | 692 |
|
|
2022
Q1 | $1.71M | Hold |
104,829
| – | – | 0.01% | 654 |
|
|
2021
Q4 | $1.45M | Hold |
104,829
| – | – | 0.01% | 719 |
|
|
2021
Q3 | $1.51M | Buy |
+104,829
| New | +$1.51M | 0.01% | 716 |
|